期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021; 27 (6)
BACKGROUND: Asthma is one of the leading chronic disease states in pediatric patients in Texas. Pharmacy-led interventions such as targeted asthma edu......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021; 27 (1)
Results of randomized controlled trials (RCTs) provide valuable comparisons of 2 or more interventions to inform health care decision making; however,......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021; 27 (3)
BACKGROUND: The 2015 American Society of Clinical Oncology guidelines recommend first-line treatment of hormone receptor (HR)-positive breast cancer w......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020; 26 (4)
BACKGROUND: Medication adherence is frequently suboptimal in adults with chronic diseases, resulting in negative consequences. Traditional interventio......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020; 26 (9)
BACKGROUND: Hemophilia A (HA) can result in bleeding events because of low or absent clotting factor VIII (FVIII). Prophylactic treatment for severe H......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019; 25 (1)
BACKGROUND: Reliance on prescription opioids to manage pain has been associated with increases in diversion, overdose, and addiction. Prevalence of mi......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019; 25 (2)
BACKGROUND: No study has investigated the cost and effectiveness of androgen deprivation therapy (ADT) and other curative treatment therapies among th......
期刊： JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019; 25 (8)
BACKGROUND: Disease-modifying antirheumatic drugs (DMARDs) are recommended as the standard of care for patients with rheumatoid arthritis (RA) due to ......
